
What smart money is saying about SI-BONE Inc.
SIBN
No fund has written a full thesis on SI-BONE Inc. in our archive, but 7 fund letters report a position in it, most recently Granahan Investment Management SMID Select Strategy in September 2026.
Get an email when a fund buys, sells or pitches it
7
Reported positions
0
Bought
0
Sold
7
Letters
Position history
Between Q3 2025 and Q3 2026, 7 fund letters reported a position in SI-BONE Inc., with no move described.
| Quarter | Letters | Bought | Sold | Theses |
|---|---|---|---|---|
| Q3 2026 | 4 | 0 | 0 | 0 |
| Q2 2026 | 2 | 0 | 0 | 0 |
| Q3 2025 | 1 | 0 | 0 | 0 |
Bought and Sold count moves: the same sentence published by several funds of one house in a quarter counts once.
Fund activity · 7 positions
- September 2026
“Top Ten Holdings Security LifeCycle Category Percent of Portfolio Silicon Motion Technology Corp. Special Situation 10.0% Porch Group Inc. Pioneer 9.7% Magnite Inc Core Growth 9.7% Digital Turbine, Inc. Special Situation 8.4% FTAI Aviation Ltd Core Growth 5.5% Sharkninja Inc. Core Growth 4.7% Chime Financial Inc. Core Growth 4.1% SI-BONE Inc. Pioneer 4.1%”
SI-BONE Inc. - September 2026
“3Q26 Contributors 3Q26 Detractors 1. Magnite, Inc. (Comm. Services, Core Growth) 2. Porch Group (Financials, Pioneer) 3. Chime Financial (Financials, Core Growth) 4. SI-BONE, Inc. (Health Care, Pioneer) 5. SharkNinja, Inc. (Consumer Disc., Core Growth)”
SI-BONE Inc. - September 2026
“5. SI-BONE, Inc. (Health Care, Pioneer)”
SI-BONE Inc. - September 2026
“Health Care Innovation from Discovery to Treatment Repligen and Twist Bioscience provide complementary exposure to the drug-development process, and both contributed positively during the quarter. Twist supplies synthetic DNA used in discovery and screening, while Repligen supports bioprocessing as biologic therapies move toward clinical development and commercial manufacturing. AI-enabled discovery could expand the number of development programs over time, although that potential remains a longer-term opportunity rather than a prerequisite for our investment theses. GRAIL and SI-BONE also contributed positively, illustrating the breadth of health care opportunities across cancer detection and surgical treatment.”
SI-BONE Inc. - June 2026
“SI-BONE Inc. Pioneer 3.8%”
SI-BONE Inc. “Top Ten Holdings Security Life Cycle Category Percent of Portfolio Silicon Motion Technology Corp. Special Situation 3.6% Porch Group Inc. Pioneer 3.5% Digital Turbine, Inc. Special Situation 2.3% Casella Waste Systems, Inc. Core Growth 2.0% Magnite Inc Core Growth 1.9% Gates Industrial Corp Special Situation 1.9% Indie Semiconductor Inc. Special Situation 1.8% Onto Innovation Inc. Special Situation 1.8% RBC Bearings Inc Core Growth 1.8% SI-BONE Inc. Pioneer 1.8%”
SI-BONE Inc.- HoldsVela Small Cap FundSeptember 2025
“Medical device company, S-Bone, Inc. (SIBN), was a detractor to performance despite reporting strong quarterly results, including 22% revenue growth and a 25% increase in active US physicians. The stock price declined largely due to concerns around modest sequential revenue deceleration implied by management guidance. We were encouraged by fundamental performance during the quarter and our estimate of intrinsic value was unchanged.”
SI-BONE Inc.
Read the letters behind these SI-BONE Inc. positions
Every quote above comes from a fund letter in our archive. Get unlimited access to the letters themselves, and to Warren AI, which reads all of them for you.
View plans→Share this ledger